Cardio3 BioSciences Strengthens Management Team by Appointing Dr. Gaëtane Metz as Chief Operating Officer
10/7/2013 9:06:25 AM
MONT-SAINT-GUIBERT, Belgium, October 7, 2013 /PRNewswire/ --
The Belgian biotechnology company Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces the appointment of Dr. Gaëtane Metz as Chief Operating Officer in view of accelerating the industrialization process and preparing the commercialization of its lead product C-Cure®.
Help employers find you! Check out all the jobs and post your resume.